Steve E Krognes's Net Worth
Steve E Krognes's net worth is estimated to be at least $7,783,211.33 as of 11/09/2024. CoreStreet's estimation of Steve E Krognes's net worth is based on their sale of stock and current holding of stock.
Steve E Krognes is Director at Denali Therapeutics Inc. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 30,000 units of DNLI stock on 09/30/2024. Their biggest sale was on 01/15/2021 when they sold 50,000 units of Denali Therapeutics Inc stock for $3,572,500.00. They typically trade 3 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $7,783,211.33
Most recent insider trade:
- Sept. 30, 2024
Steve E Krognes's Insider Trading History
| Denali Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 30, 2024 | Director | 30,000 | $29.03 | Sell | $870,900.00 |
July 1, 2024 | Director | 30,000 | $22.12 | Sell | $663,600.00 |
April 1, 2024 | Director | 92,500 | $20.50 | Sell | $1,896,250.00 |
Feb. 13, 2024 | Director | 2,750 | $17.29 | Sell | $47,547.50 |
Jan. 5, 2024 | Director | 3,208 | $19.43 | Sell | $62,331.44 |
Aug. 21, 2023 | Director | 1,419 | $22.60 | Sell | $32,069.40 |
Feb. 13, 2023 | Director | 2,119 | $30.10 | Sell | $63,781.90 |
Feb. 8, 2023 | Director | 1,377 | $30.88 | Sell | $42,521.76 |
Jan. 5, 2023 | Director | 2,970 | $28.44 | Sell | $84,466.80 |
Aug. 19, 2022 | Director | 2,253 | $33.22 | Sell | $74,844.66 |
Feb. 11, 2022 | CFO | 2,560 | $34.69 | Sell | $88,806.40 |
Feb. 9, 2022 | CFO | 1,296 | $37.09 | Sell | $48,068.64 |
Jan. 5, 2022 | CFO | 2,225 | $44.75 | Sell | $99,568.75 |
Feb. 9, 2021 | CFO | 1,448 | $74.68 | Sell | $108,136.64 |
Jan. 15, 2021 | CFO | 50,000 | $71.45 | Sell | $3,572,500.00 |
March 30, 2020 | CFO | 1,428 | $19.48 | Sell | $27,817.44 |